Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer
Clinical trial NCT07416253 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07416253
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-03-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.